Equasym | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Equasym
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Methylphenidate Hydrochloride

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Equasym

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 19 USDMF, 17 CEP/COS, 2 JDMF, 4 EU WC, 9 KDMF, 20 NDC API, 15 Listed Suppliers, $ API Reference Price

43 API Suppliers
19 USDMF
17 CEP/COS
2 JDMF
4 EU WC
9 KDMF
20 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

45 Drugs in Development

45 Drugs in Development

FINISHED DOSAGE FORMULATIONS

587 FDF Dossiers, 262 FDA Orange Book, 200 Europe, 58 Canada, 34 South Africa, 33 Listed Dossiers

587 FDF Dossiers
262 FDA Orange Book
200 Europe
58 Canada
34 South Africa
33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 18MG, TABLET, EXTENDED RELEASE;ORAL - 27MG, TABLET, EXTENDED RELEASE;ORAL - 36MG, TABLET, EXTENDED RELEASE;ORAL - 54MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 5MG/5ML, TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 20MG
TABLET;ORAL - 5MG
TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 15MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG
TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG
TABLET, EXTENDED RELEASE;ORAL - 18MG
TABLET, EXTENDED RELEASE;ORAL - 27MG
TABLET, EXTENDED RELEASE;ORAL - 36MG
TABLET, EXTENDED RELEASE;ORAL - 54MG
CAPSULE, EXTENDED RELEASE;ORAL - 10MG
CAPSULE, EXTENDED RELEASE;ORAL - 20MG
CAPSULE, EXTENDED RELEASE;ORAL - 30MG
CAPSULE, EXTENDED RELEASE;ORAL - 40MG
CAPSULE, EXTENDED RELEASE;ORAL - 50MG
CAPSULE, EXTENDED RELEASE;ORAL - 60MG
SOLUTION;ORAL - 10MG/5ML
SOLUTION;ORAL - 5MG/5ML
TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 6 Evonik, 8 Rochem International Inc, 20 SPI Pharma, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 8 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 38 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 20 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 1 Gloria Interchem, 2 Hayashibara, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 36 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 6 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 3 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

83 Fillers, Diluents & Binders, 79 Coating Systems & Additives, 49 Controlled & Modified Release, 48 Thickeners and Stabilizers, 40 Direct Compression, 39 Taste Masking, 35 Granulation, 33 Solubilizers, 30 Film Formers & Plasticizers, 29 Parenteral, 28 Topical, 27 Disintegrants & Superdisintegrants, 26 Lubricants & Glidants, 24 Chewable & Orodispersible Aids, 12 Co-Processed Excipients, 11 Emulsifying Agents, 9 Empty Capsules, 7 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

83 Fillers, Diluents & Binders
79 Coating Systems & Additives
49 Controlled & Modified Release
48 Thickeners and Stabilizers
40 Direct Compression
39 Taste Masking
35 Granulation
33 Solubilizers
30 Film Formers & Plasticizers
29 Parenteral
28 Topical
27 Disintegrants & Superdisintegrants
26 Lubricants & Glidants
24 Chewable & Orodispersible Aids
12 Co-Processed Excipients
11 Emulsifying Agents
9 Empty Capsules
7 API Stability Enhancers
5 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 71 News #PharmaBuzz

2 Data Compilation #PharmaFlow
71 News #PharmaBuzz

GLOBAL SALES INFORMATION

47 US Medicaid Prescriptions, 41 Regulatory FDF Prices, 2 Annual Reports

47 US Medicaid Prescriptions
41 Regulatory FDF Prices
2 Annual Reports

MARKET PLACE

10 APIs, 2 FDF Dossiers

10 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

224 US Patents, 57 Health Canada Patents

224 US Patents
57 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

3 EDQM
1 Others

$ API Ref.Price (USD/KG) : 629 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1Y0000910

02 1Y0001017

03 1Y0001490

filter CAS Number Reset all filters

3 All

01 1298-59-9

02 2n/a

filter Reference Standard Reset all filters

3 All

01 1Methylphenidate hydrochloride - * narc

02 1Methylphenidate impurity C

03 1Methylphenidate impurity mixture

Veranova Methylphenidate Hydrochloride

Product Main Page

01

EDQM, Council of Europe

Methylphenidate impurity mixture

BioProcess International US West

Not Confirmed

01

EDQM, Council of Europe

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Methylphenidate impurity mixture

CAS Number : n/a

Quantity Per Vial : 0.04 mg

Sale Unit : 1

Order Code : Y0000910

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Methylphenidate impurity C

BioProcess International US West

Not Confirmed

02

EDQM, Council of Europe

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Methylphenidate impurity C

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001490

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Methylphenidate hydrochloride - * narc

BioProcess International US West

Not Confirmed

03

EDQM, Council of Europe

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Methylphenidate hydrochloride - * narc

CAS Number : 298-59-9

Quantity Per Vial : 40 mg

Sale Unit : 1

Order Code : Y0001017

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.